comparemela.com

Latest Breaking News On - Phasei clinical trial - Page 5 : comparemela.com

Mitsubishi Gas Chemical : MGC Commences a Phase I Clinical Trial of Denosumab Biosimilar SPD8 in Japan

May 23, 2023 MITSUBISHI GAS CHEMICAL COMPANY, INC. MGC Commences a Phase I Clinical Trial of Denosumab Biosimilar SPD8. | May 23, 2023

Chiyoda-ku
Tokyo
Japan
Osaka
Japanese
Masashi-fujii
Denosumab-biosimilar
Public-relations-department
Head-office
Administrative-personnel-division
Devices-agency
Mitsubishi-gas-chemical-company-inc

Press Release: Omnix Medical Announces Excellent Topline Data from the Phase I Clinical Trial of its Novel Anti-Infective OMN6

Press Release: Omnix Medical Announces Excellent Topline Data from the Phase I Clinical Trial of its Novel Anti-Infective OMN6 - OMN6 demonstrates safety and tolerability at clinically significant

Netherlands
Jerusalem
Israel-general
Israel
Groningen
Ludger-wess-ines-regina-buth
Moshik-cohen-kutner
Twitter
Linkedin
Press-release
Omnix-medical-announces-excellent-topline-data
Phasei-clinical-trial

Kintor Pharmaceutical : Pharma Announces Completion of Phase I Clinical Trial of GT20029 in the US

Kintor Pharma Announces Completion of First Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China Kintor Pharma. | April 18, 2023

China
Kintor-pharma-announces-completion
First-patient-enrollment
Androgenetic-alopecia
Pharma-announces-completion
Subject-enrollment
Male-androgenetic-alopecia
Phasei-clinical-trial
Kintor-pharmaceutical-limited-stock-exchange
News
Information

Three Nonprofit Organizations Step Up to Fund Unique, Pediatric Cancer Clinical Trial - Johns Hopkins All Children's Hospital

The study will be the first to use tumor infiltrating lymphocyte therapy to address certain pediatric cancers.

Tampa
Florida
United-states
Petersburg
Sankt-peterburg
Russia
America
Ajay-gupta
Randolph-fillmore
John-mullinax
Jonathan-metts
Roswell-park-comprehensive-cancer-center

Outlook on the KRAS Inhibitors Global Market, Drug Price,

Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) The "Global KRAS Inhibitors Market, Drug Price, Sales, & Clinical Trials Insight 2029" report has been.

Japan
Shanghai
China
United-states
United-kingdom
Suzhou
Jiangsu
Canada
Dublin
Ireland
South-korea
Bridgebio-pharma

vimarsana © 2020. All Rights Reserved.